Why is accessibility such a crucial consideration of open access publishing, and how can we ensure content is sufficiently accessible?
Publishing open access saves lives: policies and barriers
How have policies and mandates helped shape open access publishing, and what barriers exist that slow their implementation?
Publishing open access saves lives: equity and benefits
What are the benefits of open access publishing, and how can we improve equity in academic and medical communications?
Guest post: The open road
For many stakeholders within the healthcare industry, the world of open research is an exciting yet occasionally confusing one. At the start of this year, key industry players from across the pharma industry met in Oxford for a roundtable discussion hosted by Wiley on ‘How the pharma–publisher relationship should evolve in the new world of … Continue reading Guest post: The open road
Combatting the next outbreak: why open access matters
As the Open Pharma position statement reaches over 100 endorsements, we share why open access is important for public health and hear why publishing house Frontiers has endorsed the position statement.
Reflecting on the release of the Open Pharma position statement on open access
Today, just over two weeks from the launch of the Open Pharma position statement on open access, we reflect on how the statement came about, the benefits it offers to different types of stakeholders and the success it has had so far.
Find out what Open Pharma achieved during Open Access Week 2019
Last week was International Open Access Week covering the topic ‘Open for whom? Equity in open knowledge’. Open Pharma kicked off this year’s Open Access Week with the launch of its position statement on open access at a MedComms Networking event in Oxford on 21 October 2019. The statement calls for publishers to allow authors … Continue reading Find out what Open Pharma achieved during Open Access Week 2019
Open science is essential for medical research, says ABPI
The Association of the British Pharmaceutical Industry (ABPI) has said that it wants to take transparency to the next level, and has committed to making clinical research more accessible and understandable across the pharmaceutical industry.
The latest scoop from Evidence-Based Medicine Live
Evidence is essential for identifying treatment priorities and developing polices, said Claire Allen of Evidence Aid, at Evidence-Based Medicine Live (EBMLive), which took place on 15–17 July in Oxford, UK.
Research discoverability – insights from the OAI 11 CERN-UNIGE Workshop on Innovations in Scholarly Communication
When it comes to driving change in academic publishing practices, much of the focus is on making research outputs freely available to all those who wish to access them. However, open access publishing is just the tip of the iceberg.